Clinical trial
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With…
NCT00329797 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00329797 |
|---|---|
| Title | Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy |
| Official title | A Phase III Randomized Study to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Prostate Cancer |
| Intervention type | Dietary Supplement, Drug, Radiation |
| Interventions | Calcium, Zoledronic acid, radiation therapy, LHRH, Vitamin D |
| Enrollment | 109 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | May 25, 2006 |
| Last update posted | Nov 29, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: